Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.17 USD | -1.36% | +11.28% | +17.30% |
Jun. 07 | Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target | MT |
May. 29 | HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target | MT |
Evolution of the average Target Price on Cognition Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cognition Therapeutics, Inc.
Chardan Research | |
HC Wainwright | |
Ladenburg Thalmann | |
B. Riley | |
Oppenheimer | |
Cantor Fitzgerald |
EPS Revisions
- Stock Market
- Equities
- CGTX Stock
- Consensus Cognition Therapeutics, Inc.